Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [1746]
News [4543]
Articles [210]
Editorials [9]
Conferences [166]
elearning [24]
Assessment of cervical and breast cancer screening in Latin America and...
Dr Isabel Mosquera - International Agency for Research on Cancer, Lyon, France
Assessment of cervical and breast cancer screening in Latin America and Caribbean: CanScreen5/CELAC project ( Dr Isabel Mosquera - International Agency for Research on Cancer, Lyon, France )
21 Nov 2022
Long-term breast cancer risk after benign breast disease in population-based...
Dr Marta Roman - Hospital del Mar Medical Research Institute, Barcelona, Spain
Long-term breast cancer risk after benign breast disease in population-based screening ( Dr Marta Roman - Hospital del Mar Medical Research Institute, Barcelona, Spain )
18 Nov 2022
Individualised breast cancer risk assessment model for BreastScreen Norway
Dr Javier Louro - Hospital del Mar Medical Research Institute, Barcelona, Spain.
Individualised breast cancer risk assessment model for BreastScreen Norway ( Dr Javier Louro - Hospital del Mar Medical Research Institute, Barcelona, Spain. )
17 Nov 2022
Trials in LMIC and HIC – are the standards applicable globally ?
Dr Amol Patel - INHS Asvini, Mumbai, India
Trials in LMIC and HIC – are the standards applicable globally ? ( Dr Amol Patel - INHS Asvini, Mumbai, India )
19 Sep 2022
Defining value based care for LMICs
Dr Bishal Gyawali - Queen's University, Kingston, Canada
Defining value based care for LMICs ( Dr Bishal Gyawali - Queen's University, Kingston, Canada )
18 Sep 2022
Cancer survivors' stories: An African perspective
Dr Zainab Shinkafi-Bagudu - Founder of the Medicaid Cancer Foundation
Cancer survivors' stories: An African perspective ( Dr Zainab Shinkafi-Bagudu - Founder of the Medicaid Cancer Foundation )
15 Sep 2022
ESMO 2022: Highlights, commentary and analysis
Dr Bishal Gyawali - Queen's University, Kingston, Canada
ESMO 2022: Highlights, commentary and analysis ( Dr Bishal Gyawali - Queen's University, Kingston, Canada )
12 Sep 2022
Sotorasib shows superior PFS and ORR compared to docetaxel for NSCLC
Dr Silvia Novello - University of Turin, Turin, Italy
Sotorasib shows superior PFS and ORR compared to docetaxel for NSCLC ( Dr Silvia Novello - University of Turin, Turin, Italy )
12 Sep 2022
ESMO 2022: Renal roundup
Dr Toni Choueiri - Dana-Farber Cancer Institute, Boston, USA
ESMO 2022: Renal roundup ( Dr Toni Choueiri - Dana-Farber Cancer Institute, Boston, USA )
12 Sep 2022
ESMO 2022: Breast cancer highlights
Dr Matteo Lambertini - San Martino Hospital, Genoa, Italy
ESMO 2022: Breast cancer highlights ( Dr Matteo Lambertini - San Martino Hospital, Genoa, Italy )
12 Sep 2022
Cabozantinib in combination w/ nivolumab and ipilimumab of IMDC intermediate or...
Dr Toni Choueiri - Dana-Farber Cancer Institute, Boston, USA
Cabozantinib in combination w/ nivolumab and ipilimumab of IMDC intermediate or poor risk significantly improved PFS vs PBO ( Dr Toni Choueiri - Dana-Farber Cancer Institute, Boston, USA )
12 Sep 2022
Emerging systemic therapies in rare urothelial cancer variants
Dr Bradley McGregor - Dana-Farber Cancer Institute, Boston, USA
Emerging systemic therapies in rare urothelial cancer variants ( Dr Bradley McGregor - Dana-Farber Cancer Institute, Boston, USA )
12 Sep 2022

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation